Search

Your search keyword '"Michaelson, Richard"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Michaelson, Richard" Remove constraint Author: "Michaelson, Richard"
23 results on '"Michaelson, Richard"'

Search Results

1. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

2. The Classification of Race, Ethnicity, Color, or National Origin (CRECNO) Initiative:A Guide to the Projected Impacts on Californians

4. Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

5. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

6. Dietary Fat Reduction and Breast Cancer Outcome: Interim Efficacy Results From the Womenʼs Intervention Nutrition Study

7. BCRA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing

10. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

11. Impact of comprehensive genomic profiling (CGP) on physician treatment recommendations in metastatic solid tumor pts who previously failed at least two standard therapies: A prospective study.

12. Activation of PI3K/AKT/mTOR pathway in ER+ breast cancer: Analysis of paired primary and metastatic tumor samples.

13. GHRH-receptor as a new targetable biomarker in breast cancer and its correlation with ER/PR/HER2 status.

15. Body mass index (BMI), tumor subtype, and relapse-free survival (RFS) in CALGB 9741 (Alliance).

16. Initial results from the 21-gene breast cancer assay registry: A prospective observational study in patients (pts) with ER+, early-stage invasive breast cancer (EBC).

17. Quantitative HER2 measurement and PI3K mutation profile in matched primary and metastatic breast cancer tissues.

18. Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy

21. VET VOICE.

23. Mitomycin- Induced Hemolytic-Uremic Syndrome: Successful Treatment With Corticosteroids and Intense Plasma Exchange

Catalog

Books, media, physical & digital resources